An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H- pyran-4-ol (D-142)

Tetrahedron Asymmetry

Volumn 22, Issue 10, 2011, Pages 1081-1086

  Gopishetty, Bhaskar ^a   Gogoi, Sanjib ^a   Dutta, Aloke K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 (ALLYLOXY)PENT 4 ENE 1,1 DIYL)DIBENZENE; 1,1 DIPHENYLPENT 4 EN 2 OL; 2 BENZHYDRYL 3,6 DIHYDRO 2H PYRAN; 2 BENZHYDRYL 5 ((4 METHOXYBENZYL)AMINO) TETRAHYDRO 2H PYRAN 4 OL 18; 2 BENZHYDRYL 5 BROMOTETRAHYDRO 2H PYRAN 4 OL; 2 BENZHYDRYLOXIRANE; 3 ((TERT BUTYLDIMETHYLSILYL)OXY) 1,1 DIPHENYLPROPAN 2 OL; 3 ((TERT BUTYLDIMETHYLSILYL)OXY) 1,1 DIPHENYLPROPAN 2 YL METHANESULFONATE; 3 HYDROXY 1,1 DIPHENYLPROPAN 2 YL METHANESULFONATE; 4 BENZHYDRYL 3,7 DIOXABICYCLO[4.1.0]HEPTANE; ALKENE; BENZHYDRYL 5 ((4 METHOXYBENZYL)AMINO) TETRAHYDRO 2H PYRAN 4 OL; TRIPLE REUPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; COLUMN CHROMATOGRAPHY; EPOXIDATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PYROLYSIS;

EID: 80051798201     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2011.05.012     Document Type: Article

References (20)

1. A. Frazer J. Clin. Psychiatry 58 1997 9 25
2. P. Delgado, and F. Moreno Int. Clin. Psychopharmacol. 14 1999 S9 S16
3. R.M. Pinder, and J.H. Wieringa Med. Res. Rev. 13 1993 259 325
4. B.J. Goldstein, and P.J. Goodnick J. Psychopharmacol. 12 1998 S55 S87
5. B.J. Goldstein J. Psychopharmacol. 12 1998 S3
6. N. Brunello, J. Mendlewicz, S. Kasper, B. Leonard, S. Montgomery, J.C. Nelson, E. Paykel, M. Versiani, and G. Racagni Eur. Neuropsychopharmacol. 12 2002 461 475
7. N. Brunello, P. Blier, L.L. Judd, J. Mendlewicz, C.J. Nelson, D. Souery, J. Zohar, and G. Racagni Int. Clin. Psychopharmacol. 18 2003 191 202
8. M. Humble Acta Psychiatr. Scand. 101 2000 28 36
9. D.T. Wong, and F.P. Bymaster Prog. Drug Res. 58 2002 169 222
10. P. Skolnick, P. Popik, A. Janowsky, B. Beer, and A.S. Lippa Eur. J. Pharmacol. 461 2003 99 104
11. A.M. Shaw, M. Boules, Y.Q. Zhang, K. Williams, J. Robinson, P.R. Carlier, and E. Richelson Eur. J. Pharmacol. 555 2007 30 36
12. S.J. Zhang, J.A. Zhen, M.E.A. Reith, and A.K. Dutta J. Med. Chem. 48 2005 4962 4971
13. S.J. Zhang, F. Fernandez, S. Hazeldine, J. Deschamps, J. Zhen, M.E.A. Reith, and A.K. Dutta J. Med. Chem. 49 2006 4239 4247
14. A.K. Dutta, B. Ghosh, S. Biswas, and M.E.A. Reith Eur. J. Pharmacol. 589 2008 73 79
15. M. Tokunaga, J.F. Larrow, F. Kakiuchi, and E.N. Jacobsen Science 277 1997 936 938
16. C.F. Sturino, and J.C.Y. Wong Tetrahedron Lett. 39 1998 9623 9626
17. B. Schmidt J. Chem. Soc., Perkin Trans. 1 1999 2627 2637
18. M. Chini, P. Crotti, L.A. Flippin, C. Gardelli, E. Giovani, F. Macchia, and M. Pineschi J. Org. Chem. 58 1993 1221 1227
19. F. Calvani, P. Crotti, C. Gardelli, and M. Pineschi Tetrahedron 50 1994 12999 13022
20. S.K. Bagal, S.G. Davies, J.A. Lee, P.M. Roberts, A.J. Russell, P.M. Scott, and J.E. Thomson Org. Lett. 12 2010 136 139